Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Merrell

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|December 31, 2020
Inferring signaling pathways with probabilistic programmingDavid Merrell, Anthony Gitter
Cell Genomics|September 10, 2025
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNAHeather A Parsons, Conor Messer, Katheryn Santos, et al.
Nature Cancer|June 3, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature Cancer|June 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature|June 25, 2025
Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactionsBrian M Andersen, Camilo Faust Akl, Michael A Wheeler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|December 31, 2020
Inferring signaling pathways with probabilistic programmingDavid Merrell, Anthony Gitter
Cell Genomics|September 10, 2025
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNAHeather A Parsons, Conor Messer, Katheryn Santos, et al.
Nature Cancer|June 3, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature Cancer|June 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature|June 25, 2025
Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactionsBrian M Andersen, Camilo Faust Akl, Michael A Wheeler, et al.
Pageof 1